Retraction notice to “Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer” [Canc. Lett. 434 (2018) 1–10]
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Upon investigation, it was discovered that 5 figures contain fabrication...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2021-10, Vol.517, p.106-106 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief. Upon investigation, it was discovered that 5 figures contain fabrication.
Figures 1C, 3D, 5C, 5D, and 6G contain manipulated and/or duplicated data.
The authors requested a corrigendum be published, however, due to the large number of corrections applied (Figs. 3, 6, 7, 8 and S3), it cannot be concluded that these changes would not alter the conclusions of the paper.
The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process. |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/j.canlet.2021.07.004 |